Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 3Duodenal Neoplasms 2Pancreatic Fistula 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pancreaticojejunostomy × 1 year × Clear all
NCT06630910 2026-03-31

whipple

Theodor Bilharz Research Institute

Phase NA Completed
48 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

NCT06756074 2026-03-16

Reinforced Pancreaticojejunostomy With or Without glubran2

Minia University

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

NCT07155525 2025-09-18

NBCA-MS

Minia University

Phase 3 Recruiting
194 enrolled
Gastrointestinal

Bile Duct Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡